AGILeBiotics is applying its platform technology, developing new antibiotics in the fast-growing markets of hospital-treated multidrug-resistant infections. Via this platform a broad variety of drug candidates can be generated, leading to new antibiotics for the treatment of hospitalized patients infected by multidrug-resistant bacteria.

Website: https://agilebiotics.com/